- Home
- ARMP vs ABLV Comparison
ARMP vs ABLV Comparison
Compare ARMP & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- ABLV
- Stock Information
- Founded
- ARMP N/A
- ABLV 2015
- Country
- ARMP United States
- ABLV China
- Employees
- ARMP N/A
- ABLV N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- ABLV
- Sector
- ARMP Health Care
- ABLV
- Exchange
- ARMP Nasdaq
- ABLV Nasdaq
- Market Cap
- ARMP 52.1M
- ABLV 58.8M
- IPO Year
- ARMP N/A
- ABLV N/A
- Fundamental
- Price
- ARMP $1.91
- ABLV $1.03
- Analyst Decision
- ARMP Strong Buy
- ABLV
- Analyst Count
- ARMP 1
- ABLV 0
- Target Price
- ARMP $9.00
- ABLV N/A
- AVG Volume (30 Days)
- ARMP 36.4K
- ABLV 9.6K
- Earning Date
- ARMP 08-12-2025
- ABLV 04-23-2025
- Dividend Yield
- ARMP N/A
- ABLV N/A
- EPS Growth
- ARMP N/A
- ABLV N/A
- EPS
- ARMP N/A
- ABLV N/A
- Revenue
- ARMP $4,699,000.00
- ABLV $128,932,647.00
- Revenue This Year
- ARMP $8.43
- ABLV N/A
- Revenue Next Year
- ARMP N/A
- ABLV N/A
- P/E Ratio
- ARMP N/A
- ABLV N/A
- Revenue Growth
- ARMP 14.24
- ABLV N/A
- 52 Week Low
- ARMP $0.90
- ABLV $0.55
- 52 Week High
- ARMP $3.42
- ABLV $1.90
- Technical
- Relative Strength Index (RSI)
- ARMP 52.83
- ABLV 42.46
- Support Level
- ARMP $1.74
- ABLV $1.05
- Resistance Level
- ARMP $2.00
- ABLV $1.19
- Average True Range (ATR)
- ARMP 0.15
- ABLV 0.10
- MACD
- ARMP -0.03
- ABLV -0.02
- Stochastic Oscillator
- ARMP 43.59
- ABLV 16.67
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.